EUR 13.06
(1.08%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 5.09 Million EUR | -41.93% |
2022 | 11.05 Million EUR | -23.85% |
2021 | 14.51 Million EUR | -64.09% |
2020 | 40.4 Million EUR | 1612.84% |
2019 | 2.35 Million EUR | -50.69% |
2018 | 4.78 Million EUR | 124.5% |
2017 | -19.52 Million EUR | -161.91% |
2016 | 31.54 Million EUR | 20.28% |
2015 | 26.22 Million EUR | 17.1% |
2014 | 22.39 Million EUR | 413.18% |
2013 | 4.36 Million EUR | 122.96% |
2012 | -19 Million EUR | -476.04% |
2011 | 5.05 Million EUR | -44.28% |
2010 | 9.07 Million EUR | -25.1% |
2009 | 12.11 Million EUR | -29.22% |
2008 | 17.11 Million EUR | 143.04% |
2007 | 7.04 Million EUR | -65.17% |
2006 | 20.21 Million EUR | 1249.2% |
2005 | 1.49 Million EUR | -89.91% |
2004 | 14.84 Million EUR | 333.27% |
2003 | 3.42 Million EUR | -37.78% |
2002 | 5.5 Million EUR | -48.49% |
2001 | 10.69 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -2.96 Million EUR | 0.0% |
2023 FY | 6.41 Million EUR | -41.93% |
2023 Q4 | 26.71 Million EUR | 0.0% |
2023 Q2 | -20.29 Million EUR | 0.0% |
2022 Q4 | 6.48 Million EUR | 0.0% |
2022 Q2 | 4.56 Million EUR | 0.0% |
2022 FY | 11.05 Million EUR | -23.85% |
2021 Q4 | 13.83 Million EUR | 0.0% |
2021 FY | 14.51 Million EUR | -64.09% |
2021 Q2 | 674 Thousand EUR | 0.0% |
2020 Q2 | -9.94 Million EUR | 0.0% |
2020 Q4 | 50.34 Million EUR | 0.0% |
2020 FY | 40.4 Million EUR | 1612.84% |
2019 FY | 2.35 Million EUR | -50.69% |
2019 Q2 | -7.11 Million EUR | 0.0% |
2019 Q4 | 7.2 Million EUR | 0.0% |
2018 Q2 | -6.66 Million EUR | 0.0% |
2018 FY | 4.78 Million EUR | 124.5% |
2017 FY | -19.52 Million EUR | -161.91% |
2017 Q2 | 14 Thousand EUR | 0.0% |
2016 Q4 | 20.58 Million EUR | 0.0% |
2016 FY | 31.54 Million EUR | 20.28% |
2016 Q2 | 10.96 Million EUR | 0.0% |
2015 Q2 | 13.29 Million EUR | 0.0% |
2015 Q4 | 12.93 Million EUR | 0.0% |
2015 FY | 26.22 Million EUR | 17.1% |
2014 Q2 | 9.6 Million EUR | 0.0% |
2014 FY | 22.39 Million EUR | 413.18% |
2013 Q4 | -412 Thousand EUR | 0.0% |
2013 FY | 4.36 Million EUR | 122.96% |
2013 Q2 | 4.77 Million EUR | 0.0% |
2012 FY | -19 Million EUR | -476.04% |
2012 Q4 | -648.75 Thousand EUR | -173.73% |
2012 Q3 | -237 Thousand EUR | 0.0% |
2012 Q2 | -237 Thousand EUR | 0.0% |
2012 Q1 | -237 Thousand EUR | 0.0% |
2011 Q2 | -15.33 Million EUR | 0.0% |
2011 Q4 | -237 Thousand EUR | 98.45% |
2011 FY | 5.05 Million EUR | -44.28% |
2011 Q3 | -15.33 Million EUR | 0.0% |
2011 Q1 | -15.33 Million EUR | 0.0% |
2010 Q3 | 6.57 Million EUR | 0.0% |
2010 FY | 9.07 Million EUR | -25.1% |
2010 Q4 | -15.33 Million EUR | -333.08% |
2010 Q1 | 6.57 Million EUR | 0.0% |
2010 Q2 | 6.57 Million EUR | 0.0% |
2009 FY | 12.11 Million EUR | -29.22% |
2009 Q3 | 3.02 Million EUR | 0.0% |
2009 Q2 | 3.02 Million EUR | 0.0% |
2009 Q4 | 6.57 Million EUR | 117.26% |
2009 Q1 | 3.02 Million EUR | 0.0% |
2008 FY | 17.11 Million EUR | 143.04% |
2008 Q4 | 3.02 Million EUR | -0.18% |
2008 Q3 | 3.03 Million EUR | 0.0% |
2008 Q2 | 3.03 Million EUR | 0.0% |
2008 Q1 | 3.03 Million EUR | 0.0% |
2007 Q4 | 3.03 Million EUR | -51.82% |
2007 FY | 7.04 Million EUR | -65.17% |
2007 Q1 | 6.29 Million EUR | 0.0% |
2007 Q2 | 6.29 Million EUR | 0.0% |
2007 Q3 | 6.29 Million EUR | 0.0% |
2006 FY | 20.21 Million EUR | 1249.2% |
2006 Q4 | 6.29 Million EUR | 4.52% |
2006 Q2 | 6.02 Million EUR | 0.0% |
2006 Q1 | 6.02 Million EUR | 0.0% |
2006 Q3 | 6.02 Million EUR | 0.0% |
2005 Q2 | 1.79 Million EUR | 0.0% |
2005 Q3 | 1.79 Million EUR | 0.0% |
2005 FY | 1.49 Million EUR | -89.91% |
2005 Q4 | 6.02 Million EUR | 236.01% |
2005 Q1 | 1.79 Million EUR | 0.0% |
2004 Q2 | 8.91 Million EUR | 0.0% |
2004 Q4 | 1.79 Million EUR | -79.9% |
2004 FY | 14.84 Million EUR | 333.27% |
2004 Q1 | 8.91 Million EUR | 0.0% |
2004 Q3 | 8.91 Million EUR | 0.0% |
2003 Q1 | -21.57 Million EUR | 0.0% |
2003 Q4 | 8.91 Million EUR | 141.33% |
2003 Q2 | -21.57 Million EUR | 0.0% |
2003 Q3 | -21.57 Million EUR | 0.0% |
2003 FY | 3.42 Million EUR | -37.78% |
2002 Q4 | -21.57 Million EUR | -5951.73% |
2002 Q3 | 368.75 Thousand EUR | 0.0% |
2002 Q1 | 368.75 Thousand EUR | 0.0% |
2002 Q2 | 368.75 Thousand EUR | 0.0% |
2002 FY | 5.5 Million EUR | -48.49% |
2001 FY | 10.69 Million EUR | 0.0% |
2001 Q4 | 368.75 Thousand EUR | 158.84% |
2001 Q3 | -626.75 Thousand EUR | 0.0% |
2001 Q1 | -626.75 Thousand EUR | 0.0% |
2001 Q2 | -626.75 Thousand EUR | 0.0% |
2000 Q4 | -626.75 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Affluent Medical SA | -13.06 Million EUR | 138.971% |
Bluelinea Société Anonyme | -1.61 Million EUR | 415.751% |
Carmat SA | -52.51 Million EUR | 109.696% |
Diagnostic Medical Systems S.A. | -2.26 Million EUR | 324.812% |
Euromedis Groupe | -5.55 Million EUR | 191.629% |
Eurobio Scientific Société anonyme | 10.14 Million EUR | 49.788% |
Ikonisys S.A. | -2.19 Million EUR | 332.116% |
Implanet S.A. | -6.15 Million EUR | 182.676% |
Median Technologies SA | -23 Million EUR | 122.133% |
SpineGuard SA | -3.97 Million EUR | 228.065% |
Theraclion SA | -3.15 Million EUR | 261.446% |
Euroapi S.A. | -234.3 Million EUR | 102.173% |
Guerbet SA | 38.67 Million EUR | 86.833% |
Koninklijke Philips N.V. | -115 Million EUR | 104.428% |
Sequana Medical NV | -29.49 Million EUR | 117.266% |